Accelerating Clinical Development and Commercialization with a Lentiviral Vector Platform Manufacturing Process for Cell Therapy.

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Attendees will learn about:
• Enhancing predictability with lentiviral vector production platforms
• Use of serum-free suspension for large-scale lentiviral vector production
• The importance of robust and reproducible results in commercial viral vector production
• Streamlining project timelines while expediting the clinical phase and moving rapidly to the commercial phase.
• Ensuring effective process validation to support commercialization of cell therapies

Speaker - Kevin Beck, Senior Manager, Miltenyi Biotech